{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:28:54Z","timestamp":1761182934243,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jiac.2016.12.011","type":"journal-article","created":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T21:45:26Z","timestamp":1484775926000},"page":"326-332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Eight unexpected cases of vancomycin associated acute kidney injury with contemporary dosing"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5184-1385","authenticated-orcid":false,"given":"J. Nicholas","family":"O'Donnell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cybele","family":"Ghossein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathaniel J.","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Lertharakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Kim","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1091-6130","authenticated-orcid":false,"given":"Marc H.","family":"Scheetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2016.12.011_bib1","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1001\/archinte.168.20.2254","article-title":"Trends in antibacterial use in us academic health centers: 2002 to 2006","volume":"168","author":"Pakyz","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jiac.2016.12.011_bib2","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1001\/jama.2014.12923","article-title":"Prevalence of antimicrobial use in us acute care hospitals, May\u2013September 2011","volume":"312","author":"Magill","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2016.12.011_bib3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1017\/ice.2015.226","article-title":"Indications and types of antibiotic agents used in 6 acute care hospitals, 2009\u20132010: a pragmatic retrospective observational study","volume":"37","author":"Kelesidis","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"year":"2016","series-title":"Standards, practice guidelines, and statements developed and\/or endorsed by IDSA","author":"America IDSo","key":"10.1016\/j.jiac.2016.12.011_bib4"},{"key":"10.1016\/j.jiac.2016.12.011_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1086\/600877","article-title":"Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists","volume":"49","author":"Rybak","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2016.12.011_bib6","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1086\/491708","article-title":"Vancomycin: a 50-year reassessment","volume":"42","author":"Moellering","year":"2006","journal-title":"Clin Infect Dis: An Official Publication of the Infectious Diseases Society of America"},{"key":"10.1016\/j.jiac.2016.12.011_bib7","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1128\/AAC.01602-07","article-title":"Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2016.12.011_bib8","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.01568-12","article-title":"Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter","volume":"57","author":"van Hal","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2016.12.011_bib9","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/jac\/dkt402","article-title":"Risk factors for nephrotoxicity in patients receiving outpatient continuous infusions of vancomycin in an Australian tertiary hospital","volume":"69","author":"Norton","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2016.12.011_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijantimicag.2015.04.013","article-title":"Vancomycin-associated nephrotoxicity: a meta-analysis of administration by continuous versus intermittent infusion","volume":"46","author":"Hanrahan","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2016.12.011_bib11","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1097\/CCM.0000000000000514","article-title":"Vancomycin-associated nephrotoxicity in the critically ill: a retrospective multivariate regression analysis*","volume":"42","author":"Hanrahan","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jiac.2016.12.011_bib12","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.clinthera.2014.05.011","article-title":"High-dose intravenous vancomycin therapy and the risk of nephrotoxicity","volume":"36","author":"Rostas","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.jiac.2016.12.011_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijantimicag.2013.11.004","article-title":"Impact of vancomycin treatment duration and dose on kidney injury","volume":"43","author":"Bosch","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2016.12.011_bib14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/cid\/cir895","article-title":"Linezolid in methicillin-resistant staphylococcus aureus nosocomial pneumonia: a randomized, controlled study","volume":"54","author":"Wunderink","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2016.12.011_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.etp.2010.07.010","article-title":"Protective role of curcumin in nephrotoxic oxidative damage induced by vancomycin in rats","volume":"64","author":"Ahmida","year":"2012","journal-title":"Exp Toxicol Pathol: Official Journal of the Gesellschaft fur Toxikologische Pathologie"},{"key":"10.1016\/j.jiac.2016.12.011_bib16","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1440-1681.2007.04695.x","article-title":"Novel evidence suggesting an anti-oxidant property for erythropoietin on vancomycin-induced nephrotoxicity in a rat model","volume":"34","author":"Cetin","year":"2007","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.jiac.2016.12.011_bib17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1179\/135100002125000884","article-title":"Inhibition of vancomycin-induced nephrotoxicity by targeting superoxide dismutase to renal proximal tubule cells in the rat","volume":"7","author":"Nishino","year":"2002","journal-title":"Redox Rep: Communications in Free Radical Research"},{"key":"10.1016\/j.jiac.2016.12.011_bib18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tox.2005.07.009","article-title":"In\u00a0vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine","volume":"215","author":"Oktem","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.jiac.2016.12.011_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00591-16","article-title":"Evaluation of vancomycin exposures associated with elevations in novel urinary biomarkers of acute kidney injury in vancomycin-treated rats","author":"Rhodes","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2016.12.011_bib20","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure \u2013 definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (adqi) group","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"key":"10.1016\/j.jiac.2016.12.011_bib21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/600884","article-title":"Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients","volume":"49","author":"Lodise","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2016.12.011_bib22","doi-asserted-by":"crossref","first-page":"436856","DOI":"10.4061\/2011\/436856","article-title":"Biopsy-proven acute tubular necrosis due to vancomycin toxicity","volume":"2011","author":"Shah-Khan","year":"2011","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.jiac.2016.12.011_bib23","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/phar.1428","article-title":"Comparison of acute kidney injury during treatment with vancomycin in combination with piperacillin-tazobactam or cefepime","volume":"34","author":"Gomes","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jiac.2016.12.011_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/kisup.2011.34","article-title":"Section 4: contrast-induced AKI","volume":"2","author":"Group KDIGOKAKIW","year":"2012","journal-title":"Kidney Int Suppl (2011)"},{"key":"10.1016\/j.jiac.2016.12.011_bib25","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2214\/ajr.181.6.1811463","article-title":"Guidelines for contrast media from the European Society of Urogenital Radiology","volume":"181","author":"Thomsen","year":"2003","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.jiac.2016.12.011_bib26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/1071576031000061002","article-title":"Targeting superoxide dismutase to renal proximal tubule cells attenuates vancomycin-induced nephrotoxicity in rats","volume":"37","author":"Nishino","year":"2003","journal-title":"Free Radic Res"},{"key":"10.1016\/j.jiac.2016.12.011_bib27","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nbt.1623","article-title":"Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies","volume":"28","author":"Vaidya","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jiac.2016.12.011_bib28","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/ndt\/gfh170","article-title":"Biopsy-proven anuric acute tubular necrosis associated with vancomycin and one dose of aminoside","volume":"19","author":"Sokol","year":"2004","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.jiac.2016.12.011_bib29","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s10157-011-0559-1","article-title":"Biopsy-proven vancomycin-associated interstitial nephritis and acute tubular necrosis","volume":"16","author":"Htike","year":"2012","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.jiac.2016.12.011_bib30","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3109\/0886022X.2012.655683","article-title":"Biopsy-proven acute tubular necrosis associated with vancomycin in an adult patient","volume":"34","author":"Belen","year":"2012","journal-title":"Ren Fail"},{"key":"10.1016\/j.jiac.2016.12.011_bib31","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1007\/s00467-006-0152-0","article-title":"Biopsy-proven acute tubular necrosis in a child attributed to vancomycin intoxication","volume":"21","author":"Wicklow","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jiac.2016.12.011_bib32","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1080\/08860220701643773","article-title":"Biopsy proven acute tubular necrosis associated with vancomycin in a child: case report and literature review","volume":"29","author":"Wu","year":"2007","journal-title":"Ren Fail"},{"key":"10.1016\/j.jiac.2016.12.011_bib33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.clinthera.2011.12.013","article-title":"Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the impact-hap database","volume":"34","author":"Cano","year":"2012","journal-title":"Clin Ther"},{"key":"10.1016\/j.jiac.2016.12.011_bib34","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.clinthera.2007.06.014","article-title":"A\u00a0retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant staphylococcus aureus pneumonia","volume":"29","author":"Jeffres","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.jiac.2016.12.011_bib35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/jhm.946","article-title":"Elevated vancomycin trough is not associated with nephrotoxicity among inpatient veterans","volume":"7","author":"Prabaker","year":"2012","journal-title":"J\u00a0Hosp Med"},{"key":"10.1016\/j.jiac.2016.12.011_bib36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/j.1875-9114.2011.01017.x","article-title":"Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohort","volume":"32","author":"Kullar","year":"2012","journal-title":"Pharmacotherapy"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X16302872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X16302872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:56:37Z","timestamp":1761159397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X16302872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1341321X16302872"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2016.12.011","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eight unexpected cases of vancomycin associated acute kidney injury with contemporary dosing","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2016.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}